Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Beyond lymph node staging: molecular predictors of outcome in breast cancer.

Surgical oncology clinics of North America - 1 Jan 2005

Sheldon David G

Abstract excerpt

This article briefly reviews the exciting, yet unproven, reports of alternate methods of predicting outcomes in breast cancer and highlights new molecular methods of diagnosing, classifying, and treating this disease. The author starts by reviewing well-known factors in breast cancer with which all alternate methods of staging and predicting outcomes must be compared prospectively.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lymphatic Metastasis
Share to Breast Neoplasms
Share to Genetic Markers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lymph Nodes

Share to Neoplasm Staging

Share to Oligonucleotide Array Sequence Analysis

Share to Prognosis

Share to Treatment Outcome

Source

Identifiers

PMID: 15542000
DOI: 10.1016/j.soc.2004.07.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Beyond lymph node staging: molecular predictors of outcome in breast cancer.PMID 15542000Read ↗

Molecular prognostic indicators for breast cancer.Semantic proximity Read ↗

Advances in prognostic and predictive biomarkers for breast cancer: Integrating multigene assays, hormone receptors, and emerging circulating biomarkersSemantic proximity Read ↗

Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up?Semantic proximity Read ↗

[Metastatic breast cancer in the spine : Molecular predictors for choosing adequate treatment strategies].Semantic proximity Read ↗

Prognostic and predictive indicators in operable breast cancer.Semantic proximity Read ↗

New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survival.Semantic proximity Read ↗

Beyond Nodal Status: Interactions Between Molecular Subtype, Tumor Burden, and Survival in 12,225 Patients with Breast CancerSemantic proximity Read ↗

Prognostic nomograms for hormone receptor-positive breast cancer with lung metastasis: a SEER-based studySemantic proximity Read ↗

Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.Semantic proximity Read ↗

A combination of Nottingham prognostic index (NPI) and IHC4 score as a cost-effective tool in the risk stratification of breast cancer patientsSemantic proximity Read ↗

Prognostic markers in triple-negative breast cancer.Semantic proximity Read ↗

Prognostic molecular markers in early breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.